Common Contracts

13 similar null contracts by IIOT-OXYS, Inc., Hancock Jaffe Laboratories, Inc., AzurRx BioPharma, Inc., Cure Pharmaceutical Holding Corp.

COMMON STOCK PURCHASE WARRANT IIOT-OXYS, INC.
IIOT-OXYS, Inc. • June 23rd, 2020 • Services-prepackaged software • Nevada

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received Vidhyadhar Mitta, or his assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth and in the Securities Purchase Agreement between the Company and the Holder (the “Purchase Agreement”), at any time on or after the Original Issue Date and on or prior to the close of business on the fifth anniversary of the Original Issue Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from IIOT-OXYS, INC, a Nevada corporation (the “Company”), up to 156,250 Common Shares (as subject to adjustment hereunder, the “Warrant Shares”); provided, however, the number of Warrant Shares exercisable pursuant to this Warrant shall increase from 50% to 100% in the Event of Default (as defined in the Note) has occurred and has not been cured. The purchase price of one (1) Common Share under this Warrant shall be equal to the

AutoNDA by SimpleDocs
COMMON STOCK PURCHASE WARRANT IIOT-OXYS, INC.
IIOT-OXYS, Inc. • June 23rd, 2020 • Services-prepackaged software • Nevada

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received Vidhyadhar Mitta, or his assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth and in the Securities Purchase Agreement between the Company and the Holder (the “Purchase Agreement”), at any time on or after the Original Issue Date and on or prior to the close of business on the fifth anniversary of the Original Issue Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from IIOT-OXYS, INC, a Nevada corporation (the “Company”), up to 156,250 Common Shares (as subject to adjustment hereunder, the “Warrant Shares”); provided, however, the number of Warrant Shares exercisable pursuant to this Warrant shall increase from 50% to 100% in the Event of Default (as defined in the Note) has occurred and has not been cured. The purchase price of one (1) Common Share under this Warrant shall be equal to the

COMMON STOCK PURCHASE WARRANT IIOT-OXYS, INC.
IIOT-OXYS, Inc. • August 8th, 2019 • Services-prepackaged software • Nevada

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received Vidhyadhar Mitta, or his assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth and in the Securities Purchase Agreement between the Company and the Holder (the “Purchase Agreement”), at any time on or after the Original Issue Date and on or prior to the close of business on the fifth anniversary of the Original Issue Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from IIOT-OXYS, INC, a Nevada corporation (the “Company”), up to 468,750 Common Shares (as subject to adjustment hereunder, the “Warrant Shares”); provided, however, the number of Warrant Shares exercisable pursuant to this Warrant shall increase from 50% to 100% in the Event of Default (as defined in the Note) has occurred and has not been cured. The purchase price of one (1) Common Share under this Warrant shall be equal to the

COMMON STOCK PURCHASE WARRANT IIOT-OXYS, INC.
IIOT-OXYS, Inc. • March 12th, 2019 • Services-prepackaged software • New York

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received [____________________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth and in the Securities Purchase Agreement between the Company and the Holder (the “Purchase Agreement”), at any time on or after the Original Issue Date and on or prior to the close of business on the fifth anniversary of the Original Issue Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from IIOT-OXYS, INC, a Nevada corporation (the “Company”), up to [__________] Common Shares (as subject to adjustment hereunder, the “Warrant Shares”); provided, however, the number of Warrant Shares exercisable pursuant to this Warrant shall increase from 50% to 100% in the Event of Default (as defined in the Notes) has occurred and has not been cured. The purchase price of one Common Share under this Warrant shall be equal

COMMON STOCK PURCHASE WARRANT IIOT-OXYS, INC.
IIOT-OXYS, Inc. • January 23rd, 2019 • Services-prepackaged software • Nevada

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received Cambridge MedSpace, LLC, a Massachusetts limited liability company, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth and in the Securities Purchase Agreement between the Company and the Holder (the “Purchase Agreement”), at any time on or after the Original Issue Date and on or prior to the close of business on the fifth anniversary of the Original Issue Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from IIOT-OXYS, INC, a Nevada corporation (the “Company”), up to 36,667 Common Shares (as subject to adjustment hereunder, the “Warrant Shares”); provided, however, the number of Warrant Shares exercisable pursuant to this Warrant shall increase from 50% to 100% in the Event of Default (as defined in the Note) has occurred and has not been cured. The purchase price of one (1) Commo

AMENDED AND RESTATED COMMON STOCK PURCHASE WARRANT Hancock Jaffe Laboratories, Inc.
Hancock Jaffe Laboratories, Inc. • April 16th, 2018 • Surgical & medical instruments & apparatus • New York

THIS AMENDED AND RESTATED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received [*] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth and in the Securities Purchase Agreement, dated as of January 5, 2018, by and among Hancock Jaffe Laboratories, Inc., a Delaware corporation (the “Company”) and the Holders signatory thereto, as amended, modified or supplemented from time to time in accordance with its terms (as it may be amended, amended and restated or otherwise modified from time to time, the “Purchase Agreement”), at any time on or after the Original Issue Date and on or prior to the close of business on the fifth (5th) anniversary of the Original Issue Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from the Company, subject to adjustment as set forth in Section 2.2(a)(iii) of the Purchase Agreement, up to a number of shares of the Co

SECOND AMENDED AND RESTATED COMMON STOCK PURCHASE WARRANT HANCOCK JAFFE LABORATORIES, INC
Hancock Jaffe Laboratories, Inc. • April 16th, 2018 • Surgical & medical instruments & apparatus • New York

THIS SECOND AMENDED AND RESTATED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received [ ] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth and in the Securities Purchase Agreement, dated June 15, 2017, by and among Hancock Jaffe Laboratories, Inc., a Delaware corporation (the “Company”) and the investors party thereto (as it may be amended, amended and restated or otherwise modified from time to time, the “Purchase Agreement”), at any time on or after the Original Issue Date and on or prior to the close of business on the fifth anniversary of the Original Issue Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from the Company, up to a number of shares of the Company’s common stock, par value $0.00001 per share, (the “Common Stock”) equal to one hundred percent (100%) of the number of shares of Common Stock issued upon conversion of the

COMMON STOCK PURCHASE WARRANT CURE PHARMACEUTICAL HOLDING CORP
Cure Pharmaceutical Holding Corp. • March 26th, 2018 • Plastics, foil & coated paper bags • New York

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received [*] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth and in the Securities Purchase Agreement, dated as of February [*], 2018, by and among CURE Pharmaceutical Holding Corp , a Nevada corporation (the “Company”) and the Holders signatory thereto, as amended, modified or supplemented from time to time in accordance with its terms (the “Purchase Agreement”), at any time on or after the Original Issue Date and on or prior to the close of business on the third anniversary of the Original Issue Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from the Company, subject to adjustment as set forth in Section 3 herein, up to a number of shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”) equal to fifty percent (50%) of the number of shares of Common Stock

COMMON STOCK PURCHASE WARRANT IIOT-OXYS, INC.
IIOT-OXYS, Inc. • February 13th, 2018 • Services-prepackaged software • New York

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received [*] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth and in the Securities Purchase Agreement between the Company and the Holder (the “Purchase Agreement”), at any time on or after the Original Issue Date and on or prior to the close of business on the fifth anniversary of the Original Issue Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from IIOT-OXYS, INC, a Nevada corporation (the “Company”), up to [*] Common Shares (as subject to adjustment hereunder, the “Warrant Shares”); provided, however, the number of Warrant Shares exercisable pursuant to this Warrant shall increase from 50% to 100% in the Event of Default (as defined in the Notes) has occurred and has not been cured. The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as de

AMENDED AND RESTATED COMMON STOCK PURCHASE WARRANT HANCOCK JAFFE LABORATORIES, INC
Hancock Jaffe Laboratories, Inc. • January 26th, 2018 • Surgical & medical instruments & apparatus • New York

THIS AMENDED AND RESTATED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received [ ] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth and in the Securities Purchase Agreement, dated June 15, 2017, as amended, among Hancock Jaffe Laboratories, Inc., a Delaware corporation (the “Company”) and the investors party thereto (the “Purchase Agreement”), at any time on or after the Original Issue Date and on or prior to the close of business on the fifth anniversary of the Original Issue Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from the Company, up to a number of shares of the Company’s common stock, par value $0.00001 per share, (the “Common Stock”) equal to seventy-five percent (75%) of the number of shares of Common Stock issued upon conversion of the Holder’s Note at the applicable Conversion Price under the Note (as subject to adjustm

COMMON STOCK PURCHASE WARRANT Hancock Jaffe Laboratories, Inc.
Hancock Jaffe Laboratories, Inc. • January 26th, 2018 • Surgical & medical instruments & apparatus • New York

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received [*] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth and in the Securities Purchase Agreement, dated as of January [__], 2018, by and among Hancock Jaffe Laboratories, Inc., a Delaware corporation (the “Company”) and the Holders signatory thereto, as amended, modified or supplemented from time to time in accordance with its terms (the “Purchase Agreement”), at any time on or after the Original Issue Date and on or prior to the close of business on the fifth (5th) anniversary of the Original Issue Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from the Company, subject to adjustment as set forth in Section 2.2 (a)(iii) of the Purchase Agreement, up to a number of shares of the Company’s common stock, par value $0.00001 per share (the “Common Stock”) equal to fifty percent (50%)

COMMON STOCK PURCHASE WARRANT HANCOCK JAFFE LABORATORIES, INC
Hancock Jaffe Laboratories, Inc. • December 14th, 2017 • Surgical & medical instruments & apparatus • New York

THIS COMMON UNIT PURCHASE WARRANT (the “Warrant”) certifies that, for value received [ ] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth and in the Securities Purchase Agreement between the Company and the Holder (the “Purchase Agreement”), at any time on or after the Original Issue Date and on or prior to the close of business on the fifth anniversary of the Original Issue Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Hancock Jaffe Laboratories, Inc, a Delaware corporation (the “Company”), up to [ ] Common Shares (as subject to adjustment hereunder, the “Warrant Shares”); provided, however, the number of Warrant Shares exercisable pursuant to this Warrant shall increase from 50% to 75% (i) in the event the Company does not consummate an IPO by January 11, 2018 or (ii) in the event and Event of Default (as defined in the Notes) has occurred and has not be

AMENDED AND RESTATED COMMON STOCK PURCHASE WARRANT AZURRX BIOPHARMA, INC.
AzurRx BioPharma, Inc. • September 8th, 2015 • Pharmaceutical preparations • New York

THIS AMENDED AND RESTATED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received [______________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth and in the Amended and Restated Securities Purchase Agreement between the Company and the Holder (the “Purchase Agreement”), at any time on or after the Initial Exercise Date and on or prior to the close of business on the fifth anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from AzurRx BioPharma, Inc., a Delaware corporation (the “Company”), up to [_________] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Time is Money Join Law Insider Premium to draft better contracts faster.